Dexcom, Inc.: Will Sensor Tech Advancements Solidify Its Lead In Continuous Glucose Monitoring? 

DexCom Inc.’s latest earnings for the fourth quarter of 2024 reports a period of strategic growth and investment, aligning with the company’s guidance and expectations. The company achieved an 8% organic revenue growth in the fourth quarter year-over-year, with full-year organic growth at 12%. An increase in the customer base by approximately 25% to over 2.8 million globally was a critical driver of this growth. The broadening commercial reach and strategic product launches have cemented DexCom’s leading position in the biosensing market.